insights_auto
Why is TNXP down 7,10%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
USD 3,01
arrow_downward
-7,10%(-0,23) 1D
13 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
USD 3,25
High
USD 3,25
Low
USD 2,90
Mkt. cap
58,49 m
Avg. vol.
1,12 m
Volume
1,94 m
52-wk high
USD 20,56
52-wk low
USD 2,90
EPS
-USD 12,92
Beta
1,90
Shares outstanding
19,43 m
No. of employees
142
Open
USD 3,25
High
USD 3,25
Low
USD 2,90
Mkt. cap
58,49 m
Avg. vol.
1,12 m
Volume
1,94 m
52-wk high
USD 20,56
52-wk low
USD 2,90
EPS
-USD 12,92
Beta
1,90
Shares outstanding
19,43 m
No. of employees
142
News stories
From web sources and news partners
Yahoo Finance
·
1 dag gelede
TNXP 8-K & SEC Filings
Yahoo Finance
·
2 dae gelede
Tonix Pharmaceuticals (TNXP) Stock Fair Value Falls As Analysts Weigh Tonmya And Funding Risk
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitetonixpharma.com